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Uterine cervical cancerThe cases
Two patients visited the outpatient department for vaginal spotting.
Biopsies were performed and uterine cervical cancer was conﬁrmed.
They wanted to preserve their fertility.
Case no. 1
The patient was a 29-year-old single woman with squamous cell
carcinoma with 3×4×5 cm3 in size and clinical stage was Ib2. The
lesion restored to almost normal state after completion of the ﬁrst
Concurrent Chemo-Photodynamic Therapy (CCPDT) in September
13, 2005. Then, we observed the perfect normal cervix after the second
CCPDT. Thereafter, all follow up studies such as pap smear, HPV DNA
test, colposcopic biopsy, endocervical curettage, and PET-CT showed
normal status for the last 6 years. She got married a year after comple-
tion of a CCPDT course and got pregnant 2 years later via IVF & ET.
Then, a 2.97 kg female baby was ﬁnally born with full term normal
spontaneous delivery at the gestation age of 39 weeks. Six years has
passed since CCPDT treatment, and she still has no recurrence of uterine
cervical cancer (Fig. 1).⁎ Corresponding author at: Department of Obstetrics and Gynecology, School of
Medicine, Chosun University, Gwang-ju, Republic of Korea 501-717. Fax: +82 62 232
2310.
E-mail address: sjhan@chosun.ac.kr (S.-J. Han).
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Open access under CC BY-NC-ND license .Case no. 2
The patient was a 28-year-old single woman with squamous cell
carcinoma with 2.5×2.5×2.5 cm3 in size. This patient was also an
unmarried woman, and the clinical stage of her cancer was Ib1. The
ﬁrst CCPDT was done on Jan. 16, 2006 and the second one was per-
formed 6 weeks later. Every procedure of the protocol was the same
as the previous case. After completion of CCPDT, the results of all follow
up studies were negative. After she got married she became pregnant
spontaneously and had a cesarean operation due to cephalo-pelvic
disproportion at the gestational age of 40 weeks and 3 days, 43rd
month since the CCPDT. There has been no evidence of recurrent
cancer for 6 years until now (Fig. 2).
Discussion
Cervical cancer is the second most common cancer in women with
half a million cases world-wide, resulting in approximately 274,000
deaths yearly (Parkin et al., 2005); it is an important life threatening
disease in Korea since its mortality ranks second highest among
the gynecologic cancers. No matter how much those reproductive
patients want to become pregnant, most of them must remove
their reproductive organ. Recently, simple trachelectomy or conization
with or without high-dose-intensity neoadjuvant chemotherapy
(NACT) was introduced; however, we were worried about reduction
or cessation of ovarian function for successful pregnancy from NACT
and even if NACT is performed, operation would be essential after
chemotherapy. Also, the following operation has some serious problems
that may lead to operative complications, cancer recurrence, infertility,
lower pregnancy rate, high miscarriage rate, cervical cerclage, preterm
labor and another classical cesarean section (Ishioka et al., 2007). Thus,
we sought to ﬁnd other ways to solve these problems that can
cure cancer completely while sparing the reproductive organ perfectly
without chemotherapy or any operation.
Photodynamic therapy has been used to cervical intraepithelial
lesions and it showed a positive result (Istomin et al., 2010 Sep).
Although PDT has a mechanism based on apoptosis and necrosis for
cancer treatment, it has limitations to treating cervical cancer with
conventional Photofrin-PDT due to relatively short tissue penetration
depth of less than 5 mm (Shackley et al., 2000). So, we have developed
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just like Concurrent Chemo-Radio-Therapy. Patient choice is very
important because PDT is not applicable for metastatic lesions beyond
the cervix. The indications for CCPDT are as follows:
(1) young women, who have a strong desire to keep up their uterus
and cervix.
(2) cervical cancer should be conﬁned to the cervix (less than
stage 1b).
(3) absolutely for those who refuse an operation or RT.
Protocol of CCPDT are as follows.
1. Forty-eight hours to PDT, intravenous injection of photosensitizer
(hematoporphyrin derivative: Photogem® 2.5 mg/kg or Photofrin®
2 mg/kg).
2. Three hours prior to PDT, administration of carboplatin with dose
of 75 mg/m2.
3. Irradiation of laser light (CERALA™ Diode Laser 632 System, Biolitec,
Germany ) with ﬂuence rate of 240 J/cm2 on the exocervix and
250 J/cm in the endocervix using ﬂat cut lens and using cylindrical
lens, respectively.
4. Same amount of energy was delivered at 48 hours post-PDT as
booster.
5. Efﬁcacy of the treatmentwas evaluated in the 3, 6, 9 month post-PDT
with cytology, HPV DNA test and Cervigram™ or colposcopy.
Low dose of carboplatin that we used was not for NACT but for
photochemical internalization (PCI). PCI is an important concept in
CCPDT. It is based on the light activation of photosensitizers speciﬁcally
located in the membrane of endocytic vesicles that induce the rupture
of this membrane upon illumination. By doing so, the endocytosed
molecules can be released to reach their target of action before being
degraded in lysosomes. This has been shown to enhance the biological
activity of a large variety of macromolecules and other molecules that
do not readily penetrate the plasmamembrane in site-speciﬁc manner.
Thereby our CCPDT may take advantage of the PCI effect as a photody-
namic therapy with concurrent use of chemotherapy when administer-
ing carboplatin that is invaginated into vesicles (Høgset et al., 2004). On
the other hand, platinum series were chosen among the chemothera-
peutic agents because these may lead to relatively large quantumyield of singlet oxygens even in hypo-oxygenation tissue state as
observed in palladium–porphyrin complex (Wiehe and Stollberg,
2001) or enhanced susceptibility of cancer cells to carboplatin-
induced cytotoxicity by intracellular ROS produced by PDT (Matsui et
al., 2007). All patients were counseled and were informed about the
possibility of the operation and cancer recurrence after CCPDT.
All patients demonstrated remarkable results, preserving their
fertility. It is very interesting that this method can avoid operations,
any complications, recurrences and adjuvant therapies for uterine
cervical cancer up to now, and that safe full term delivery could be
successful simultaneously. In conclusion CCPDT could be a new treatment
option for uterine cervical cancer that can preserve fertility, and further
studies and multicenter trials remain to elucidate safety and therapeutic
mechanism.
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